514 related articles for article (PubMed ID: 11874478)
1. Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars.
Szulgit G; Rudolph R; Wandel A; Tenenhaus M; Panos R; Gardner H
J Invest Dermatol; 2002 Mar; 118(3):409-15. PubMed ID: 11874478
[TBL] [Abstract][Full Text] [Related]
2. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study of actin and myosin in the scar tissue].
Zhang Q; Qian YL; Cui L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):32-5. PubMed ID: 12563927
[TBL] [Abstract][Full Text] [Related]
4. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
5. Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars.
Nakaoka H; Miyauchi S; Miki Y
Acta Derm Venereol; 1995 Mar; 75(2):102-4. PubMed ID: 7604635
[TBL] [Abstract][Full Text] [Related]
6. Fibrillin-1 and elastin are differentially expressed in hypertrophic scars and keloids.
Amadeu TP; Braune AS; Porto LC; Desmoulière A; Costa AM
Wound Repair Regen; 2004; 12(2):169-74. PubMed ID: 15086768
[TBL] [Abstract][Full Text] [Related]
7. Regulation of collagen gene expression in keloids and hypertrophic scars.
Friedman DW; Boyd CD; Mackenzie JW; Norton P; Olson RM; Deak SB
J Surg Res; 1993 Aug; 55(2):214-22. PubMed ID: 8412102
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of collagen in hypertrophic and keloid cicatrix].
Podobed OV; Prozorovskiĭ NN; Kozlov EA; Tsvetkova TA; Vozdvizhenskiĭ SI; Del'vig AA
Vopr Med Khim; 1996; 42(3):240-5. PubMed ID: 9139458
[TBL] [Abstract][Full Text] [Related]
9. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models.
Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S
Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604
[TBL] [Abstract][Full Text] [Related]
10. [Variations of lipid peroxidation products and copper, zinc-superoxide dismutase in pathological scars].
Li W; Cen Y; Wang H; Chen W; Liu D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):838-41. PubMed ID: 18681286
[TBL] [Abstract][Full Text] [Related]
11. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
Ogawa R
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
[TBL] [Abstract][Full Text] [Related]
12. mTOR as a potential therapeutic target for treatment of keloids and excessive scars.
Ong CT; Khoo YT; Mukhopadhyay A; Do DV; Lim IJ; Aalami O; Phan TT
Exp Dermatol; 2007 May; 16(5):394-404. PubMed ID: 17437482
[TBL] [Abstract][Full Text] [Related]
13. [The expression of tenascin-C mRNA in keloids and hypertrophic scars].
Han CM; He XJ; Ma Q
Zhonghua Zheng Xing Wai Ke Za Zhi; 2005 Jan; 21(1):40-3. PubMed ID: 15844597
[TBL] [Abstract][Full Text] [Related]
14. Hypertrophic and keloid scars fail to progress from the CD34
Limandjaja GC; Belien JM; Scheper RJ; Niessen FB; Gibbs S
Br J Dermatol; 2020 Apr; 182(4):974-986. PubMed ID: 31206605
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
Ogawa R; Akaishi S
Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
Sato M
Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
19. Keloids and hypertrophic scars: are they two different sides of the same coin?
Köse O; Waseem A
Dermatol Surg; 2008 Mar; 34(3):336-46. PubMed ID: 18177398
[TBL] [Abstract][Full Text] [Related]
20. The structure of the basement membrane zone differs between keloids, hypertrophic scars and normal skin: a possible background to an impaired function.
Hellström M; Hellström S; Engström-Laurent A; Bertheim U
J Plast Reconstr Aesthet Surg; 2014 Nov; 67(11):1564-72. PubMed ID: 25037500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
